22nd Century Group Inc (XXII) Given $3.50 Consensus Price Target by Brokerages
22nd Century Group Inc (NYSE:XXII) has been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.
Analysts have set a 12-month consensus price objective of $3.50 for the company, according to Zacks. Zacks has also assigned 22nd Century Group an industry rank of 202 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research upgraded 22nd Century Group from a “hold” rating to a “buy” rating and set a $2.50 price objective for the company in a report on Saturday, August 26th.
COPYRIGHT VIOLATION WARNING: “22nd Century Group Inc (XXII) Given $3.50 Consensus Price Target by Brokerages” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/09/16/22nd-century-group-inc-xxii-given-3-50-consensus-price-target-by-brokerages.html.
Shares of 22nd Century Group (XXII) traded up 6.29% on Wednesday, reaching $3.21. The company’s stock had a trading volume of 7,935,159 shares. The company has a 50 day moving average price of $2.28 and a 200 day moving average price of $1.62. The company’s market cap is $329.86 million. 22nd Century Group has a 52-week low of $0.81 and a 52-week high of $3.34.
In other news, VP Michael Robert Moynihan sold 29,532 shares of 22nd Century Group stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $2.00, for a total value of $59,064.00. Following the completion of the sale, the vice president now directly owns 917,220 shares in the company, valued at $1,834,440. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Large investors have recently made changes to their positions in the stock. National Asset Management Inc. increased its stake in 22nd Century Group by 13.7% in the first quarter. National Asset Management Inc. now owns 172,000 shares of the biotechnology company’s stock valued at $204,000 after acquiring an additional 20,700 shares during the last quarter. Virtu KCG Holdings LLC grew its stake in shares of 22nd Century Group by 300.9% during the second quarter. Virtu KCG Holdings LLC now owns 126,106 shares of the biotechnology company’s stock worth $221,000 after buying an additional 94,650 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of 22nd Century Group by 17.6% during the second quarter. Vanguard Group Inc. now owns 2,894,322 shares of the biotechnology company’s stock worth $5,065,000 after buying an additional 432,450 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of 22nd Century Group by 22.3% during the second quarter. Northern Trust Corp now owns 133,797 shares of the biotechnology company’s stock worth $234,000 after buying an additional 24,401 shares during the last quarter.
About 22nd Century Group
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for 22nd Century Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.